ҹ꽲вٯҡ»վ꽲վɶطǿꁶһûϸȥһѵ˳㵴滹е㡰ζ
ɶȡζе˼
ҿվɶҪǻᡰTTһȤЩϽ֡ҰζſҡȱͷβСζһžǡԼˡġ꽲Ȥ
һмСֹζӣͷʱʽڹҽطԭǸͷŇӣ
͵͵꽲мС̯糿ȥŻڼҰϸݹζֵùֺŇӣȥȻʱܾ̯ˡ
ġ桱Ҫʱ䣡
ϲՇվҲмԡƩ糿ʱߴůůɫҰζ
һǻƻʱϵְ̫Ұӡֻijʱ⡱ζӡ
͵͵꽲иͷַС˻Ҫеסײǽϻǰ̱껭ӣ
ܻʇӣǾֵֵȥ
ҿʱԣぶһ䡰ζȥǺõġҪʱ뿴ɶÁ
ؽ꽲ǁ
ǩ»վ桢Ͻζͷվܺ
ַ¥Ʒ̳ۡ
źгչͼӡڡҪΪѡƷΪҪӡṩܡҪԴɡϵӡҪܼߵĴӡƷʺͱܼԻ᳡ĸʵʱļӦϵͳ칫ʵʱЭͬÿһϸڶ뾫һӡ֤˱ͼƷʸЧſɿԽƷʵˡҪñͼҪñͼ
̫ԭڽ
131չ˾2025ҵԤԤʵ־68.00Ԫ78.00Ԫͬȱ任Ϊ51.00%~73.00%
ɽ·ƽֵĿܼ
֮һʱܹͨϸֳָܻȻܺõġԵлЧϰ֬ԸףMetabolic dysfunction-associated steatohepatitis, MASHԲѬȾþƾʱƾͻʧء̫Ծ̻ᵼϸʣExtracellular matrixĴڳԭĸ֯ӲγɸάLiver fibrosisһ̲ӸԤתӲΰ
͵͵꽲иͷַС˻Ҫеסײǽϻǰ̱껭ӣ